Advances and gaps in SARS-CoV-2 infection models.

Research output: Contribution to journalReview articleResearchpeer-review

3 Citations (Scopus)

Abstract

The global response to Coronavirus Disease 2019 (COVID-19) is now facing new challenges such as vaccine inequity and the emergence of SARS-CoV-2 variants of concern (VOCs). Preclinical models of disease, in particular animal models, are essential to investigate VOC pathogenesis, vaccine correlates of protection and postexposure therapies. Here, we provide an update from the World Health Organization (WHO) COVID-19 modeling expert group (WHO-COM) assembled by WHO, regarding advances in preclinical models. In particular, we discuss how animal model research is playing a key role to evaluate VOC virulence, transmission and immune escape, and how animal models are being refined to recapitulate COVID-19 demographic variables such as comorbidities and age.
Original languageEnglish
JournalPLoS Pathogens
Volume18
Issue number1
DOIs
Publication statusPublished - 13 Jan 2022

Fingerprint

Dive into the research topics of 'Advances and gaps in SARS-CoV-2 infection models.'. Together they form a unique fingerprint.

Cite this